Metabolic Phenotyping During Stress Hyperglycemia in Cardiac Surgery Patients
Status:
Recruiting
Trial end date:
2022-10-01
Target enrollment:
Participant gender:
Summary
The study is a prospective randomized study to examine the effects of exposure to dulaglutide
on the prevention of stress-hyperglycemia and the metabolic inflammatory response in the
perioperative period
Phase:
Phase 4
Details
Lead Sponsor:
Emory University
Collaborator:
National Institute of General Medical Sciences (NIGMS)
Treatments:
Anesthetics Dulaglutide Immunoglobulin Fc Fragments Pharmaceutical Solutions